Macro photograph of a pipette dispensing a clear droplet above a dark laboratory surface

Peptide marketing agency

Marketing that
survives the
review.

Peptide brands don't need another channel list. They need positioning, claim boundaries, and acquisition infrastructure that hold up to search scrutiny, ad-platform policy, and buyers who research everything before they act.

01

Research-use-only suppliers

02

Telehealth & peptide clinics

03

Peptide ecommerce brands

01 — The premise

The channel isn’t the problem. The operating model is.

Positioning · Claim boundaries · Search · Paid media · Intake

Peptide brands do not need another shallow list of channels. They need a marketing system that can survive search scrutiny, ad-platform review, customer skepticism, ecommerce friction, and medical or compliance review — without losing lead quality along the way.

That is why the strongest peptide marketing strategies begin before a campaign is ever launched. The work starts with positioning, claim boundaries, offer structure, website clarity, tracking, and a realistic understanding of how people research peptide products and services.

Marketing here has to do two jobs at once: create demand and reduce confusion. A prospect may arrive with questions about consultation steps, product categories, eligibility, safety expectations, provider oversight, shipping, repeat ordering, or what a company is legally allowed to say. If the brand only talks about growth, results, or transformation, the marketing may attract clicks while creating risk, low trust, and weak conversion.

01

Business model first

A clinic, an RUO supplier, and an ecommerce brand can share vocabulary but never share a strategy.

02

Claims are infrastructure

Substantiation and platform policy decide which campaigns can exist at all — not the media buyer.

03

Educate before you sell

Peptide buyers research process, eligibility, sourcing, and risk before they ever request a consult.

02 — Industries

One category.
Three operating models.

Same search phrases, different responsibilities. Choose the model that matches how your business actually earns revenue.

Research use only

Sell to researchers without drifting into human-use claims.

Catalog-driven suppliers of research peptides, lab supplies, and reference materials with a compliance-sensitive audience.

What breaks

  • Consumer treatment intent leaking into product pages and ad copy
  • Category pages that rank for the wrong intent
  • Ad accounts flagged for health and supplement language

What we build

  • Research-use boundary language across every template
  • Category architecture mapped to real research queries
  • Policy-reviewed campaigns and conservative creative sets
  • Account, shipping, and documentation clarity at checkout
Amber glass vials with black caps lit by cold and gold light on a dark laboratory bench

Model / RUO supplier

03 — Services

The system behind
the spend.

01

Positioning & claim map

We define who you serve, what the business can responsibly say, and where the boundary sits — before a single campaign exists.

02

Educational SEO

Own research-heavy demand with pages that answer process, eligibility, sourcing, category, and trust questions in plain language.

03

Paid acquisition & policy review

Google, Meta, and short-form campaigns written to clear health, supplement, and prescription review instead of triggering it.

04

Landing pages & conversion

Offer-matched pages, forms, disclaimers, and intake steps that turn qualified research into booked consultations.

05

CRM & lead automation

Routing, follow-up sequences, call tracking, and reporting, so an inquiry never dies in an inbox you forgot to check.

06

Creative & video

Conservative, substantiated creative that reads clinical rather than hyped — built for review, not for a screenshot.

04 — Process

Strategy. Build. Launch. Scale.

A peptide engagement does not start with a media plan. It starts with the constraint that is actually slowing growth — and a written decision about what the business can responsibly say.

01

Business-model map

We define the operating model: the offer, the claims, the intake path, the market, and what should happen after a form is submitted. Every channel gets a job from this map.

Deliverable — Positioning brief, claim boundary document

02

Build the assets

Site structure, category and service pages, landing pages, forms, disclaimers, tracking, and CRM wiring. Built to be reviewed before they are promoted.

Deliverable — Pages, intake flow, tracking plan

03

Launch with review in view

Conservative copy, clean conversion events, narrow campaigns, and a standing plan for disapprovals, restrictions, and appeals. Nothing clever that puts the account at risk.

Deliverable — Live campaigns, policy log, reporting

04

Scale what converts

We cut what produces cheap unqualified leads and reinvest in the channels that produce booked consultations — measured against the CRM, not the ad platform.

Deliverable — Monthly review, budget reallocation

05 — Claim boundaries

What we
won’t build.

Compliance-conscious messaging is not polish applied at the end. It is the constraint that makes the rest of the plan possible. We say no to work that would put an account, a license, or a patient at risk — early, in writing, before anyone spends money.

We do not sell peptides. We do not prescribe. We do not write clinical advice.

Out of scope

  • Unsupported health, outcome, or performance claims
  • Consumer treatment intent built into a research-use-only catalog
  • Copy that implies a personal attribute, condition, or diagnosis
  • Funnels that skip provider oversight, eligibility, or intake
  • Prescription or compounded-drug promotion outside platform policy

What we do instead

  • Substantiated language with a documented source for every claim
  • Research-use boundaries that stay visible across every template
  • Consultation-first paths with oversight written into the flow
  • Campaigns built inside the platform rules, or not built at all

06 — Evidence

Representative engagements.

Client names withheld. Each engagement is described by the decision that changed the result, not by the channel we billed for.

Research use only

Category restructure and claim-boundary rewrite

Rebuilt a 40-page catalog around research intent, replaced consumer-facing language with a documented boundary, and rebuilt the intake path for account requests.

2.4×

Organic sessions to category pages

0

Ad disapprovals in 90 days

Telehealth clinic

Consultation funnel and call tracking

Moved the primary conversion from a form fill to a booked consultation, added call tracking with source attribution, and rebuilt intake around eligibility and oversight.

+41%

Booked consultations

−28%

Cost per booked call

Peptide ecommerce

Product education and retention flows

Built comparison and FAQ content for the top categories, then layered email and SMS flows on category and reorder behavior instead of a single blast calendar.

+33%

Repeat order rate

2.1×

Email revenue per subscriber

Anonymized engagements. Results depend on offer, market, budget, and compliance posture; they are not a guarantee of future performance.

07 — Diagnostic

How much of your growth is blocked by the foundation?

Six questions, about a minute. You get an honest score and the three things we would fix first — no call required.

0 / 6 answered

01

Does your homepage explain what you sell and who it is for — without outcome claims?

Rewrite the homepage around offer, audience, and process, and remove any claim you cannot substantiate in writing.

02

Does every product or service page answer sourcing, eligibility, or process questions?

Add a process and eligibility block to each category and service page — the questions buyers ask before they trust you.

03

Is your ad copy reviewed against platform policy before each launch?

Create a pre-launch review checklist covering health, supplement, and prescription language, plus the source for each claim.

04

Do you track which inquiries become booked consultations?

Wire call tracking and CRM stages so spend is measured against booked calls instead of form fills.

05

Do you publish educational content that search and AI answers can cite?

Publish structured FAQ, process, and category explainers that both search engines and buyers can actually use.

06

Is your claim boundary documented, with someone accountable for approving it?

Write a one-page claim boundary: approved language, prohibited language, substantiation, and sign-off.

08 — Insights

Field notes on peptide growth.

Peptide Marketing Strategy: How to Choose What to Fix First

A peptide marketing strategy should help you find where the customer path breaks, then focus time and budget on the fix that matters to your business.

Read article

How to Set Up Ads for Peptide Brands: A Prelaunch Checklist

A practical prelaunch checklist for peptide ads: confirm channel fit, align the offer and landing page, set up measurement, and plan the review.

Read article

5 Marketing Tips for Peptide Brands That Improve Website Conversion

Five practical website changes peptide business owners can make to clarify the offer, improve inquiry flow, and measure what happens next.

Read article

09 — Questions

The questions we get asked first.

If yours is not here, ask it on a call. We would rather disqualify ourselves early than bill for a mismatch.

Do you work with research-use-only brands?

Yes. RUO is one of our three core models. We keep research-use boundaries visible across the site, the product templates, and the ad copy, and we build acquisition around research intent rather than consumer treatment intent. If a request would pull the brand into human-use claims, we decline it in writing before work starts.

Can you run ads for peptide products?

Sometimes. Google restricts some healthcare, prescription, and pharmaceutical advertising, and consumer platforms restrict health, wellness, weight-management, and supplement content. Some categories require certification and some cannot be advertised at all. We review the specific product category against current policy before any creative is produced, and tell you if the channel is closed.

Are you a clinic, or do you provide medical advice?

No. We are a marketing and acquisition agency. We do not sell peptides, prescribe, or write clinical advice. Telehealth clients remain responsible for licensure, clinical oversight, and the accuracy of their own claims.

What does an engagement look like?

Most engagements start with a business-model map and claim boundary, then move into asset build and launch. It is a monthly retainer, with media spend billed separately and in your own accounts. The first month is usually strategy and infrastructure, not spend.

How quickly can we launch?

Typically three to six weeks, depending on how much site work is required and how long internal or legal review takes. Brands with a clean site and a documented claim boundary move faster.

Do you guarantee ad approvals or results?

No — and be careful with anyone who does. Platform review is outside our control, and results depend on offer, market, budget, and compliance posture. What we can promise is that nothing launches without a policy pass and a substantiation path.

10 — Contact

Book a
strategy call.

Tell us what you sell and where growth is stuck. We will tell you whether the constraint is marketing, the offer, or the compliance posture — and what we would do about it.

  • A 30-minute call about the business model, not a pitch deck.
  • We review your site, category pages, and current claims before we talk.
  • You leave with a written next step — even if it is not us.

We do not sell peptides, prescribe, or provide medical advice. RUO brands must maintain research-use-only positioning.

Request a strategy call

Name(Required)
Email(Required)
Please let us know what's on your mind. Have a question for us? Ask away.

No newsletter. No sequences. One reply from a person.

Please do not include patient details or sensitive health information.